Fisogatinib Uses, Dosage, Side Effects and more
Fisogatinib is under investigation in clinical trial NCT04194801 (A Phase Ib/ii Study of Fisogatinib(blu-554) in Subjects With Hepatocellular Carcinoma).
| Trade Name | Fisogatinib |
| Generic | Fisogatinib |
| Fisogatinib Other Names | Fisogatinib |
| Type | |
| Formula | C24H24Cl2N4O4 |
| Weight | Average: 503.38 Monoisotopic: 502.1174607 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
